VaxCheck成人全生命周期疫苗接种服务的接受度与结局:社区药师中的一项研究
该前瞻性描述性研究在加拿大安大略省9家社区药房开展VaxCheck咨询,共123次咨询,平均年龄60岁,95.1%的咨询产生至少一种疫苗推荐,平均每人推荐三种疫苗,但仅5.9%的推荐疫苗在咨询时接种。患者反馈积极,85%的受访者同意或强烈同意推荐该服务。
要点
- VaxCheck咨询中95.1%产生至少一种疫苗推荐,平均每人三种。
- 仅5.9%的推荐疫苗在咨询时接种,受药师处方/接种权限和公共资助疫苗可及性限制。
- 85%的受访者同意或强烈同意向他人推荐该服务。
核心结论
- 社区药师通过VaxCheck咨询可主动识别患者所需的疫苗,但接种率低,建议扩大执业范围和公共资助疫苗可及性以支持疫苗接种。
研究设计与样本
- 前瞻性描述性研究,2022年10月至2023年5月在加拿大安大略省9家社区药房(Wholehealth Pharmacy Partners旗下)开展123次VaxCheck咨询。
主要发现
- 患者平均年龄60岁,35.8%有至少一种慢性病风险因素,17.7%有生活方式相关风险因素,15.4%免疫功能低下。
- 95.1%的VaxCheck咨询产生至少一种疫苗推荐,平均每人推荐三种疫苗。
- 最常推荐的疫苗为肺炎球菌病、破伤风/白喉、带状疱疹、COVID-19和流感疫苗,无需处方且药房免费提供的疫苗接受率最高。
- 仅5.9%的推荐疫苗在咨询时接种,常受药师处方和/或接种疫苗的执业范围限制以及药房无法获得符合资格者公共资助疫苗供应的影晌。
- 85%的受访者同意或强烈同意向他人推荐该服务。
临床怎么用
- 作者建议扩大执业范围和公共资助疫苗的可及性,以进一步支持疫苗接种。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination rates among Canadian adults remain suboptimal. Community pharmacists have increasingly adopted an active role in vaccination and are trusted by the public to provide vaccination-related advice and care. The aim of this prospective descriptive study was to develop and test a novel clinical service, VaxCheck, to support proactive life-course vaccination assessments by community pharmacists. From October 2022-May 2023, 123 VaxCheck consultations were performed at 9 community pharmacies within the Wholehealth Pharmacy Partners banner in Ontario, Canada. Patient age averaged 60 years and 35.8 % had at least one chronic disease risk factor, 17.7 % had lifestyle-related risk factor(s), and 15.4 % were immunocompromised. 95.1 % of VaxCheck consultations resulted in at least one vaccine recommendation, averaging three vaccines per patient. Most frequently recommended vaccines were those against pneumococcal disease, tetanus/diphtheria, herpes zoster, COVID-19, and influenza, with acceptance rates highest for those available without a prescription and at no charge at the pharmacy. Patient feedback was positive with 85 % of respondents agreeing or strongly agreeing that they would recommend the service to others. Vaccine administration at the time of the consultation occurred with only 5.9 % of recommended vaccines, frequently impacted by limitations to scope of practice related to pharmacist ability to prescribe and/or administer the vaccine and lack of pharmacy access to publicly funded vaccine supply for those meeting eligibility criteria. Community pharmacists performing a VaxCheck consultation can proactively identify indicated vaccines for patients. Expansion in scope of practice and access to publicly funded vaccine is recommended to further support vaccine uptake.
引用
- Houle SKD, Waite NM, Vernon-Wilson E, et al. Uptake and outcomes of VaxCheck, an adult life-course vaccination service: A study among community pharmacists. Vaccine. 2024. PMID: 38955590. doi:10.1016/j.vaccine.2024.06.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。